Aim: To compare oral nifedipine and intravenous labetalol in the treatment of acute severe hypertension in pregnancy (SHP).
Methods: The primary outcomes were the required time to achieve target blood pressure (RTATBP), systolic blood pressure (SBP) and diastolic BP (DBP) after treatment, secondary outcomes were the number of doses (NoD) and adverse events (AEs).
Results: There was no difference between oral nifedipine and intravenous labetalol in SBP, DBP, and AE. However, oral nifedipine provided less RTATBP and NoD.
Conclusion: Oral nifedipine was associated with less RTATBP and NoD and otherwise did not differ from intravenous labetalol.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/10641955.2023.2209637 | DOI Listing |
Publication Analysis
Top Keywords
oral nifedipine
20
intravenous labetalol
12
acute severe
8
severe hypertension
8
hypertension pregnancy
8
nifedipine intravenous
8
blood pressure
8
oral
5
nifedipine preferential
4
preferential option
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!